Probing Hot Spots at Protein−Ligand Binding Sites:  A Fragment-Based Approach Using Biophysical Methods

Journal of Medicinal Chemistry
2006.0

Abstract

Mapping interactions at protein-ligand binding sites is an important aspect of understanding many biological reactions and a key part of drug design. In this paper, we have used a fragment-based approach to probe "hot spots" at the cofactor-binding site of a model dehydrogenase, Escherichia coli ketopantoate reductase. Our strategy involved the breaking down of NADPH (Kd = 300 nM) into smaller fragments and the biophysical characterization of their binding using WaterLOGSY NMR spectroscopy, isothermal titration calorimetry (ITC), and inhibition studies. The weak binding affinities of fragments were measured by direct ITC titrations under low c value conditions. The 2'-phosphate and the reduced nicotinamide groups were found to contribute a large part of the binding energy. A combination of ITC and site-directed mutagenesis enabled us to locate the fragments at separate hot spots on opposite ends of the cofactor-binding site. This study has identified structural determinants for cofactor recognition that represent a blueprint for future inhibitor design.

Knowledge Graph

Similar Paper

Probing Hot Spots at Protein−Ligand Binding Sites:  A Fragment-Based Approach Using Biophysical Methods
Journal of Medicinal Chemistry 2006.0
Binding Evaluation of Fragment-Based Scaffolds for Probing Allosteric Enzymes
Journal of Medicinal Chemistry 2012.0
Fragment-Based Deconstruction of Bcl-x<sub>L</sub> Inhibitors
Journal of Medicinal Chemistry 2010.0
Deconstruction of a Nutlin: Dissecting the Binding Determinants of a Potent Protein–Protein Interaction Inhibitor
ACS Medicinal Chemistry Letters 2013.0
Surface Plasmon Resonance Biosensor Based Fragment Screening Using Acetylcholine Binding Protein Identifies Ligand Efficiency Hot Spots (LE Hot Spots) by Deconstruction of Nicotinic Acetylcholine Receptor α7 Ligands
Journal of Medicinal Chemistry 2010.0
INPHARMA-based identification of ligand binding site in fragment-based drug design
MedChemComm 2012.0
Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds
Journal of Medicinal Chemistry 2021.0
Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein–Protein Interactions?
ACS Medicinal Chemistry Letters 2014.0
‘Tethering’ fragment-based drug discovery to identify inhibitors of the essential respiratory membrane protein type II NADH dehydrogenase
Bioorganic &amp; Medicinal Chemistry Letters 2018.0
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery
Journal of Medicinal Chemistry 2016.0